Abstract
Aims:
To identify asthma patients who have experienced a non-consented switch (NCS) of their inhaler device and to explore the circumstances and impact of these switches.
Methods:
Nineteen asthma patients who had experienced an NCS of their inhaler device were recruited to participate in qualitative, semi-structured one-to-one interviews.
Results:
All 19 participants reported a switch in their asthma inhaler without consultation or approval. There was deterioration in asthma control reported by some participants, many remained unchanged, and two reported better outcomes. Regardless of any change in asthma control, all patients expressed discontent with the NCS. Many felt it had damaged their relationship with their doctor, their confidence in their asthma medication, and their perception of control over their disease.
Conclusions:
These qualitative interviews highlight the need to maintain clear and open communication with patients. Switching of patients' inhalers without their consent may diminish the self-control associated with good asthma management, leave the doctor-patient relationship damaged, increase resource utilisation, and waste medication.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
AW was an employee of GlaxoSmithKline during the time the study was being conducted. DP has consultant arrangements with: Aerocrine, Boehringer Ingelheim, Dey Pharmaceuticals, GlaxoSmithKline (GSK), Merck, Sharpe and Dohme (MSD), Novartis, Schering-Plough and Teva. He or his team have received grants and research support for research in respiratory disease from the following organisations: UK National Health Service, Aerocrine, AstraZeneca, Boehringer Ingelheim, GSK, MSD, Novartis, Pfizer, Schering Plough and Teva. He has spoken for: Boehringer.
SD, AL, HC, MM, MT have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Doyle, S., Lloyd, A., Williams, A. et al. What happens to patients who have their asthma device switched without their consent?. Prim Care Respir J 19, 131–139 (2010). https://doi.org/10.4104/pcrj.2010.00009
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.4104/pcrj.2010.00009
This article is cited by
-
How to Choose the Right Inhaler Using a Patient-Centric Approach?
Advances in Therapy (2022)
-
Environmental Sustainability in Respiratory Care: An Overview of the healthCARe-Based envirONmental Cost of Treatment (CARBON) Programme
Advances in Therapy (2022)
-
Association of Nonmedical Switches in Inhaled Respiratory Medications with Disruptions in Care: A Retrospective Prescription Claims Database Analysis
Pulmonary Therapy (2021)
-
General Practitioner Use of Generically Substitutable Inhaler Devices and the Impact of Training on Device Mastery and Maintenance of Correct Inhaler Technique
Pulmonary Therapy (2020)
-
Difference in resistance to humidity between commonly used dry powder inhalers: an in vitro study
npj Primary Care Respiratory Medicine (2016)
